BioHealth News Archive
Producing cures, Emergent BioSolutions works to protect people around the world – YouTube
Emergent Biosolutions produces cures in Downtown Baltimore for cancer patients, troops and stockpiles in case of a chemical attack. {iframe}https://www.youtube.com/watch?v=MuQ_lqQ-o4Y{/iframe}
Read More
Maryland firm acquires Johns Hopkins startup Fractal Technology – Technical.ly Baltimore
Fractal Technology, a startup founded at Johns Hopkins, was recently acquired by Annapolis Junction–based Sunayu, according to the cofounders. {iframe}https://technical.ly/baltimore/2017/09/12/fractal-technology-sunayu-acquisition/?utm_campaign=Baltimore%20Editorial%20Email&utm_source=hs_email&utm_medium=email&utm_content=56232268&_hsenc=p2ANqtz-9SHylfubMC7Rb8QqZP4cD_HAWiRYbElid6hfcKg73Qzbe9-6lbDHLwpGRmI7VJW903kWRAJUoymTBNYdre1ki6Q7EJ_g&_hsmi=56232268{/iframe}
Read More
Producing cures, Emergent BioSolutions works to protect people around the world – Longform story
Threats come in all sizes, some so small you can't see. The damage, however can be catastrophic. Emergent BioSolutions creates remedies for diseases like cancer…
Read More
Hopkins, Maryland, UMBC ranked among top colleges by U.S. News and World Report – Baltimore Sun
The Johns Hopkins University and the University of Maryland, College Park were ranked among the top tier in the U.S. News and World Report…
Read More
Qiagen, Angle to Comarket Liquid Biopsy Technologies | GenomeWeb
UK-based liquid biopsy firm Angle said today that it has inked a comarketing agreement with Qiagen for circulating tumor cell (CTC) technology. {iframe}https://www.genomeweb.com/business-news/qiagen-angle-comarket-liquid-biopsy-technologies{/iframe}
Read More
What Does It Cost to Create a Cancer Drug? Less Than You’d Think – The New York Times
What does it really cost to bring a drug to market? The question is central to the debate over rising health care costs and…
Read More
A $12 Billion Takeover Says That Gene Therapy Cancer Cures Are Big Business – MIT Technology Review
Pharmaceutical firm Gilead Sciences has just put up a cool $11.9 billion to acquire Kite Pharma, which has developed a genetic engineering approach for…
Read More
The growth imperative for medical-device companies – McKinsey & Company
Every year, as part of their strategic planning, executives’ minds turn to setting performance targets—and then achieving them. In so doing, those at medical-device…
Read More
Does Your Genome Predict Your Face? Not Quite Yet – MIT Technology Review
On Monday, the California gene-hunting company Human Longevity published a paper making the bold claim that it can identify individuals using their genomes to…
Read More
Quantum Dots Light Up Tumors Brighter Than Ever Before – Medgadget
Scientists at the Sanford Burnham Prebys Medical Discovery Institute (SBP) in San Diego, California have devised a way to optically image tumors with unprecedented…
Read More
Finalists selected for $250K pediatric medical device competition – 5th Pediatric Device Symposium
The National Capital Consortium for Pediatric Device Innovation (NCC-PDI) is pleased to announce the 12 finalists selected to pitch their pediatric medical device innovation…
Read More
Can Craig Venter really predict what your look like from your DNA?
Can genomics wizards make an informed guesstimate on what a person looks like, based on his or her DNA? J. Craig Venter sure thinks so,…
Read More
CEO Corner Video with BHI CEO Rich Bendis – #MOCO365
BioHealth Innovation CEO, Richard Bendis discusses with Montgomery County Economic Development Corporation for #MOCO365 how BioHealth Innovation helps accelerate the growth of life science…
Read More
Inova Names Mickey Y. Kim, MD, MBA, Senior Vice President of Research and Commercialization
Inova announced today that Mickey Y. Kim, MD, MBA, has been named Senior Vice President of Research and Commercialization. In this role, Dr. Kim…
Read More
FDA Digital Health Entrepreneur-in-Residence Program
Do you have experience in digital health? Are you passionate about developing innovative solutions to complex challenges? If so, consider joining the FDA Digital…
Read More